|
POLR3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.80190000001568E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.17960000001594E-07 |
| Normal-vs-Stage2 |
5.641900E-02 |
| Normal-vs-Stage3 |
4.734500E-02 |
| Normal-vs-Stage4 |
1.425210E-01 |
| Stage1-vs-Stage2 |
4.381800E-01 |
| Stage1-vs-Stage3 |
2.237600E-01 |
| Stage1-vs-Stage4 |
5.925400E-01 |
| Stage2-vs-Stage3 |
8.267600E-01 |
| Stage2-vs-Stage4 |
9.700400E-01 |
| Stage3-vs-Stage4 |
8.262600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51159999994821E-06 |
| Normal-vs-AfricanAmerican |
1.503500E-03 |
| Normal-vs-Asian |
1.640430E-02 |
| Caucasian-vs-AfricanAmerican |
6.591400E-01 |
| Caucasian-vs-Asian |
9.853400E-01 |
| AfricanAmerican-vs-Asian |
8.720600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.78619999796825E-08 |
| Normal-vs-Female |
2.619400E-01 |
| Male-vs-Female |
6.384100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.198300E-03 |
| Normal-vs-Extreme_Weight |
1.04370001530185E-09 |
| Normal-vs-Obese |
2.219000E-03 |
| Normal-vs-Extreme_Obese |
2.356500E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.553600E-01 |
| Normal_Weight-vs-Obese |
5.232200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.458800E-01 |
| Extreme_Weight-vs-Obese |
4.443100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.458400E-01 |
| Obese-vs-Extreme_Obese |
4.085000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.029600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.222100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.21410000053501E-07 |
| Normal-vs-Age(81-100Yrs) |
1.62880000043053E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.249700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.796350E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.224300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.580200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.535200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.169630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.68630000360903E-08 |
| Normal-VS-Type2 PRCC |
1.635460E-04 |
| Normal-VS-KIRP CIMP |
3.661600E-01 |
| Normal-VS-Unclassified PRCC |
4.040600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.289600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.369000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.656310E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.779700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.974300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.164800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.84250000000641E-05 |
| Normal-vs-N1 |
3.370600E-01 |
| Normal-vs-N2 |
5.077800E-01 |
| N0-vs-N1 |
4.283700E-02 |
| N0-vs-N2 |
5.810400E-01 |
| N1-vs-N2 |
6.976200E-01 |
|
|
